Anales de la RANM

55 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 TMR O RPNI EN PACIENTES CON AMPUTACIÓN DE EXTREMIDADES An RANM. 2026;143(01): 48 - 55 Gurpegui Gámiz D, et al. Neuroma Pain in Amputees? Clin Orthop Relat Res. 2014;472:2991-3001. 35. Raasveld FV, Hoftiezer YAJ, Gomez-Eslava B, et al. Early Postoperative Pain Course following Primary and Secondary Targeted Muscle Reinnervation: A Temporal Description of Pain Outcomes. J Reconstr Microsurg. 2025;41:459-468. 36. Raasveld FV, Mayrhofer-Schmid M, Johnston BR, et al. Targeted muscle reinnervation at the time of amputation to prevent the development of neuropathic pain. J Plast Reconstr Aesthet Surg. 2024;97:13-22. 37. Frantz TL, Everhart JS, West JM, Ly TV, Phieffer LS, Valerio IL. Targeted Muscle Reinnervation at the Time of Major Limb Amputation in Traumatic Amputees: Early Experience of an Effective Treatment Strategy to Improve Pain. JBJS Open Access. 2020;5:e0067-e0067. 38. Goodyear EG, O’Brien AL, West JM, et al. Targeted Muscle Reinnervation at the Time of Amputa- tion Decreases Recurrent Symptomatic Neuroma Formation. Plast Reconstr Surg. 2024;153:154-163. 39. Bowen JB, Ruter D, Wee C, West J, Valerio IL. Targeted Muscle Reinnervation Technique in Below-Knee Amputation. Plast Reconstr Surg. 2019;143:309-312. 40. O’Brien AL, West JM, Gokun Y, et al. Longitudinal Durability of Patient-Reported Pain Outcomes after Targeted Muscle Reinnervation at the Time of Major Limb Amputation. J Am Coll Surg. 2022;234:883-889. 41. Mahmoud MA, Toyoda Y, McGraw JR, et al. 40. Development Of Neuropathic Pain After Primary TMR And RPNI In Lower Extremity Amputation: A 4-year Retrospective Analysis Of Prognostic Factors. Plast Reconstr Surg Glob Open. 2024;12:25- 25. 42. Obinero CG, Green JC, Swiekatowski KR, et al. Surgical Complications after Targeted Muscle Reinnervation at a Safety-Net Hospital. J Reconstr Microsurg. 2025;41:531-539. 43. Elmorsi R, Shin A, Adelman DM, Mericli AF, Roubaud MJ. 52. Efficacy of Targeted Muscle Reinnervation and Regenerative Peripheral Nerve Interface in Reducing Pain in Cancer Amputees: A Patient-reported Outcomes Study. Plast Reconstr Surg Glob Open. 2025;13:26-26. 44. Reid RT, Johnson CC, Gaston RG, Loeffler BJ. Impact of Timing of Targeted Muscle Reinnerva- tion on Pain and Opioid Intake Following Major Limb Amputation. Hand (N Y). 2024;19:200-205. 45. Pejkova S, Nikolovska B, Srbov B, et al. Prophylactic Regenerative Peripheral Nerve Interfaces in Elective Lower Limb Amputations. PRILOZI. 2022;43:41-48. 46. Kubiak CA, Kemp SWP, Cederna PS, Kung TA. Prophylactic Regenerative Peripheral Nerve Interfaces to Prevent Postamputation Pain. Plast Reconstr Surg. 2019;144:421e-430e. 47. Berberoglu I, Kemp SWP, Hooper RC. Regenerative Peripheral Nerve Interface (RPNI) for the Manage- ment of Postamputation Pain in Oncology Patients. Plast Reconstr Surg. 2025. Disponible en: https:// journals.lww.com/10.1097/PRS.0000000000012312 48. Eberlin KR, Brown DA, Gaston RG, et al. A Consensus Approach for Targeted Muscle Reinner- vation in Amputees. Plast Reconstr Surg Glob Open. 2023;11:e4928. Si desea citar nuestro artículo: Gurpegui Gámiz D, del Moral Preciado J. Reinervación Mus- cular Dirigida (TMR) o Interfaz Regenerativa de Nervio Periférico (RPNI) para la Prevención del Dolor en Pacien- tes con Amputación de Extremidades: Revisión Siste- mática. An RANM. 2026;143(01): 48– 55. DOI: 10.32440/ ar.2026.143.01. org01